AXSOME THERAPEUTICS, INC. Intangible Assets, Net (Excluding Goodwill)
AXSOME THERAPEUTICS, INC. (AXSM) had Intangible Assets, Net (Excluding Goodwill) of $37.36 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-10
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $37.36M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $38.95M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $40.52M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $42.13M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $37.36M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $38.95M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $40.52M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $42.13M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $43.73M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $45.32M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $46.89M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $48.50M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $50.11M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $51.70M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $53.29M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $54.89M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $56.50M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $58.09M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $59.66M 10-K · filed 2024-02-23 | $59.66M 10-K · filed 2023-02-28 |
| 2022-09-30 | $61.27M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $62.87M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |